AgingResearch.NewsJoin free

Phase 4Recruiting

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

Sponsor
The University of Texas Medical Branch, Galveston (Academic or other)
Enrollment
490 planned
Conditions
Post Operative Pulmonary Complications; Neuromuscular Blockade; General Anesthesia
Interventions
Rocuronium; Cisatracurium; Sugammadex; Neostigmine
Ages
adults, older adults
Registry
NCT07203287

Full record on ClinicalTrials.gov

From the registry

The purpose of the study is to determine which combination of neuromuscular blocking agent and reversal agent is safer to use during anesthesia for patients with chronic kidney disease. The main question it aims to answer is "The use of Cisatracurium with neostigmine leads to less post-operative pulmonary complications than Rocuronium with sugammadex."

Primary outcomes

  • Post Operative Pulmonary Complications (PPCs)

History

  1. Study completion expected

  2. Primary completion expected

  3. Last registry update

  4. Registered

  5. Started